Pharma intelligence for business development that matches your criteria.
RxClarity turns a detailed prospect, partner or asset profile into a repeatable screening job. Agents check companies and connected pipeline evidence against the same criteria, then show which signals produced each match.
LAST REVIEWED · 25 August 2026
The best opportunity is rarely the company that fits one obvious filter.
Business-development criteria often combine therapy area, stage, modality, pipeline position, company signals and softer indicators that cannot be expressed as one database query.
That leaves teams assembling longlists manually, checking candidates one at a time and repeating the screen whenever the market changes. RxClarity captures the full set of criteria and runs the same assessment consistently across companies.
Build the analysis around the decision—not the database interface.
Describe the fit in plain language
Combine pipeline, clinical, company and partnership criteria without reducing the question to one fixed taxonomy.
Separate strong and soft signals
Distinguish evidence that directly satisfies the brief from signals that warrant a closer look or a watch-list position.
See why every company matched
Each result carries the exact criterion and supporting signal that surfaced it instead of appearing as an unexplained score.
Repeat the screen as the market changes
Run the same prospect or partner assessment again without rebuilding the research process from the beginning.
Define it once. Keep running the same job against current evidence.
Define the opportunity
Set the target company, asset, indication, stage and strategic-fit criteria with your team.
Screen and explain
The agent evaluates companies against strong and soft signals and connects each match to its evidence.
Review matches and watch lists
Focus diligence and outreach on the companies that fit, while monitoring promising near-matches for change.
Qualified prospect discovery for a life-sciences consultancy screening hundreds of companies.
“RxClarity is significantly faster than our current process, and found companies we never would have identified.”
A traceable screen, not a black-box recommendation.
RxClarity shows which evidence and criteria produced a match. Your team decides which prospect, partner or asset deserves diligence and outreach.